{"entity":{"type":"insider","cik":"0001742696","url":"/insider/0001742696","json_url":"/insider/0001742696.json","name":"Koppikar Utpal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":23,"first":"2018-09-11","last":"2023-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Koppikar Utpal","source":"filing","n_filings":23,"first_seen":"2018-09-11","last_seen":"2023-03-06"}],"transactions":[{"id":8267243,"accession":"0001567619-23-004538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-004538","line_url":"/filing/0001567619-23-004538#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6871.0,"shares_display":"6,871","price_per_share":3.627,"price_display":"3.63","price_state":"stated","total_value":24921.117,"total_display":"24,921.12","total_whole":"24,921","shares_owned_after":181978.0,"shares_owned_after_display":"181,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":8340875,"accession":"0001662579-23-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001662579-23-000027","line_url":"/filing/0001662579-23-000027#line-1","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5667.0,"shares_display":"5,667","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":31735.2,"total_display":"31,735.20","total_whole":"31,735","shares_owned_after":5667.0,"shares_owned_after_display":"5,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":7879947,"accession":"0001567619-23-002174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-002174","line_url":"/filing/0001567619-23-002174#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2485.0,"shares_display":"2,485","price_per_share":5.46,"price_display":"5.46","price_state":"stated","total_value":13568.1,"total_display":"13,568.10","total_whole":"13,568","shares_owned_after":188849.0,"shares_owned_after_display":"188,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-09","scope":"insider"},{"id":6367038,"accession":"0001140361-22-042378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-042378","line_url":"/filing/0001140361-22-042378","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6255.0,"shares_display":"6,255","price_per_share":4.49017314148681,"price_display":"4.49","price_state":"stated","total_value":28086.033,"total_display":"28,086.03","total_whole":"28,086","shares_owned_after":192417.0,"shares_owned_after_display":"192,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider","n_lines":2},{"id":6604749,"accession":"0001140361-22-030297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-030297","line_url":"/filing/0001140361-22-030297#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5940.0,"shares_display":"5,940","price_per_share":5.035,"price_display":"5.04","price_state":"stated","total_value":29907.9,"total_display":"29,907.90","total_whole":"29,908","shares_owned_after":197589.0,"shares_owned_after_display":"197,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6608819,"accession":"0001567619-22-012667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012667","line_url":"/filing/0001567619-22-012667#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5853.0,"shares_display":"5,853","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":32952.39,"total_display":"32,952.39","total_whole":"32,952","shares_owned_after":203529.0,"shares_owned_after_display":"203,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":6859628,"accession":"0001140361-22-019988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-019988","line_url":"/filing/0001140361-22-019988","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5582.0,"shares_display":"5,582","price_per_share":5.316173056252239,"price_display":"5.32","price_state":"stated","total_value":29674.878,"total_display":"29,674.88","total_whole":"29,675","shares_owned_after":208558.0,"shares_owned_after_display":"208,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6604677,"accession":"0001140361-22-007767","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-22-007767","line_url":"/filing/0001140361-22-007767","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3763.0,"shares_display":"3,763","price_per_share":9.856396226415095,"price_display":"9.86","price_state":"stated","total_value":37089.619,"total_display":"37,089.62","total_whole":"37,090","shares_owned_after":214665.0,"shares_owned_after_display":"214,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":6303839,"accession":"0001567619-22-003052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-003052","line_url":"/filing/0001567619-22-003052#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2496.0,"shares_display":"2,496","price_per_share":14.4615,"price_display":"14.46","price_state":"stated","total_value":36095.904,"total_display":"36,095.90","total_whole":"36,096","shares_owned_after":155702.0,"shares_owned_after_display":"155,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":4944033,"accession":"0001567619-21-020778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020778","line_url":"/filing/0001567619-21-020778#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3655.0,"shares_display":"3,655","price_per_share":17.1169,"price_display":"17.12","price_state":"stated","total_value":62562.2695,"total_display":"62,562.27","total_whole":"62,562","shares_owned_after":157714.0,"shares_owned_after_display":"157,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":4819437,"accession":"0001567619-21-016148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016148","line_url":"/filing/0001567619-21-016148#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3579.0,"shares_display":"3,579","price_per_share":12.532,"price_display":"12.53","price_state":"stated","total_value":44852.028,"total_display":"44,852.03","total_whole":"44,852","shares_owned_after":161369.0,"shares_owned_after_display":"161,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":4562605,"accession":"0001567619-21-011898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-011898","line_url":"/filing/0001567619-21-011898#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5820.0,"shares_display":"5,820","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":81829.2,"total_display":"81,829.20","total_whole":"81,829","shares_owned_after":164948.0,"shares_owned_after_display":"164,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider"},{"id":5100471,"accession":"0001209191-21-034424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034424","line_url":"/filing/0001209191-21-034424#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3616.0,"shares_display":"3,616","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":52612.8,"total_display":"52,612.80","total_whole":"52,613","shares_owned_after":168966.0,"shares_owned_after_display":"168,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":5099068,"accession":"0001209191-21-023586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023586","line_url":"/filing/0001209191-21-023586#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1761.0,"shares_display":"1,761","price_per_share":14.58,"price_display":"14.58","price_state":"stated","total_value":25675.38,"total_display":"25,675.38","total_whole":"25,675","shares_owned_after":172582.0,"shares_owned_after_display":"172,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-30","scope":"insider"},{"id":4178045,"accession":"0001209191-21-017770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017770","line_url":"/filing/0001209191-21-017770#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1461.0,"shares_display":"1,461","price_per_share":16.74,"price_display":"16.74","price_state":"stated","total_value":24457.14,"total_display":"24,457.14","total_whole":"24,457","shares_owned_after":174343.0,"shares_owned_after_display":"174,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":4526311,"accession":"0001209191-21-009055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009055","line_url":"/filing/0001209191-21-009055#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1759.0,"shares_display":"1,759","price_per_share":20.39,"price_display":"20.39","price_state":"stated","total_value":35866.01,"total_display":"35,866.01","total_whole":"35,866","shares_owned_after":130546.0,"shares_owned_after_display":"130,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":2797846,"accession":"0001209191-20-059047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059047","line_url":"/filing/0001209191-20-059047#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1469.0,"shares_display":"1,469","price_per_share":19.774,"price_display":"19.77","price_state":"stated","total_value":29048.006,"total_display":"29,048.01","total_whole":"29,048","shares_owned_after":132061.0,"shares_owned_after_display":"132,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-18","scope":"insider"},{"id":3199517,"accession":"0001209191-20-047820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047820","line_url":"/filing/0001209191-20-047820#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1496.0,"shares_display":"1,496","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":18086.64,"total_display":"18,086.64","total_whole":"18,087","shares_owned_after":133530.0,"shares_owned_after_display":"133,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2880881,"accession":"0001209191-20-035488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-035488","line_url":"/filing/0001209191-20-035488#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3924.0,"shares_display":"3,924","price_per_share":10.18,"price_display":"10.18","price_state":"stated","total_value":39946.32,"total_display":"39,946.32","total_whole":"39,946","shares_owned_after":135026.0,"shares_owned_after_display":"135,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":3256986,"accession":"0001209191-20-031005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031005","line_url":"/filing/0001209191-20-031005#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1428.0,"shares_display":"1,428","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":16022.16,"total_display":"16,022.16","total_whole":"16,022","shares_owned_after":137375.0,"shares_owned_after_display":"137,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":3196564,"accession":"0001209191-20-021699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021699","line_url":"/filing/0001209191-20-021699#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1827.0,"shares_display":"1,827","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":16753.59,"total_display":"16,753.59","total_whole":"16,754","shares_owned_after":137330.0,"shares_owned_after_display":"137,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-27","filed_date":"2020-03-30","scope":"insider"},{"id":2412925,"accession":"0001209191-20-008125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008125","line_url":"/filing/0001209191-20-008125#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1781.0,"shares_display":"1,781","price_per_share":14.21,"price_display":"14.21","price_state":"stated","total_value":25308.01,"total_display":"25,308.01","total_whole":"25,308","shares_owned_after":72282.0,"shares_owned_after_display":"72,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-10","scope":"insider"},{"id":6662093,"accession":"0001209191-18-050564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-050564","line_url":"/filing/0001209191-18-050564#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001742696","owner_name":"Koppikar Utpal","owner_display_name":"Koppikar Utpal","owner_url":"/insider/0001742696","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":36.8,"price_display":"36.80","price_state":"stated","total_value":73600.0,"total_display":"73,600.00","total_whole":"73,600","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-27","filed_date":"2018-09-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (Chief Financial Officer)","n_filings":22,"first_seen":"2018-09-11","last_seen":"2023-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001662579","name":"C4 Therapeutics, Inc.","url":"/issuer/0001662579","role":"Director","n_filings":1,"first_seen":"2023-02-10","last_seen":"2023-02-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742696","retrieved_at":"2026-08-25T12:41:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}